So there you have it, folks! Who would have thought that ivermectin and fenbendazole, the unassuming off-patent drugs, could rise to become the unsung heroes in the battle against cancer? While Big Pharma might prefer to keep these gems hidden, their potential for revolutionizing cancer treatment cannot be ignored. It’s almost comical how these unassuming compounds, once overshadowed by their more glamorous counterparts, are now poised to shine brightly in the fight against tumors and rogue cells. So, let’s raise a glass to the unexpected heroes and their tremendous potential in conquering cancer. #UnleashingTheOffPatentHeroes #IvermectinAndFenbendazoleTakeTheStage #FightingCancerWithUnexpectedStars

Cancer remains one of the most pressing health challenges of our time, with millions of lives affected by its devastating impact. In the midst of the Wuhan coronavirus (COVID-19) pandemic, a drug called ivermectin emerged as a potential game-changer in the fight against the virus. However, recent studies have shed light on an unexpected benefit of this drug – its ability to prevent and treat cancer. This groundbreaking discovery has the potential to revolutionize cancer treatment and place ivermectin squarely in the crosshairs of the pharmaceutical industry.

Synthetic Meat and Cancer: What You Need to Know

Unveiling the Hidden Potential of Ivermectin

As individuals worldwide grappled with the effects of COVID-19, scientists made a surprising observation: taking ivermectin as a prophylactic not only provided protection against the virus but also exhibited anti-cancer properties. It became clear that ivermectin could potentially help individuals afflicted by the alarming rise of “turbo cancer,” a condition seemingly connected to the rapid development of Operation Warp Speed.

Imagine the possibilities if individuals who were “fully vaccinated” against COVID-19 had easy access to ivermectin. Many of them might find relief and healing from the drug’s potential cancer-fighting properties. Furthermore, the anti-parasitic drug fenbendazole has also shown promise in combating cancer, creating an intriguing question: What if a combination therapy utilizing both ivermectin and fenbendazole could be used for the prevention and treatment of cancer? The synergistic effect of these remarkable drugs could prove far more effective than using them individually.

The Unbelievable Truth: Unveiling the Majestic Deep State’s Exquisite Plot for Total Annihilation

The Power of Combination Therapy

When ivermectin and fenbendazole are taken together, they deliver a powerful blow to cancer. Combining them with other anti-cancer nutrients such as quercetin, vitamins C and D, and curcumin further enhances their effects. Preclinical studies have demonstrated the cytotoxic effects of both ivermectin and fenbendazole on cancer cells, effectively inhibiting tumor growth and metastasis.

Notably, the mechanisms behind these effects disrupt critical cellular processes, ultimately leading to the death of cancer cells. Sid Belzberg, a renowned researcher, highlighted these findings in a paper referenced by an esteemed reader known as the “2nd Smartest Guy in the World.”

Overcoming Obstacles to Access

Ivermectin and fenbendazole, as off-patent drugs, have become generics after the expiration of their original licenses. Consequently, various generic drug manufacturers, particularly those in India, produce these drugs abundantly and at low cost. However, in the United States, stringent regulations limit access to these drugs without a prescription, unless one purchases the versions intended for veterinary use. Nevertheless, these drugs hold incredible promise in cancer prevention and mitigation when combined with other anti-cancer vitamins and minerals.

Unfortunately, mainstream sources often provide limited information about these drugs. Since they are off-patent, pharmaceutical companies are less inclined to promote or emphasize their benefits, as the potential profits are minimal. Despite these challenges, Belzberg makes a compelling case for compounding ivermectin and fenbendazole with other complementary substances, creating a safe and effective synergistic anti-cancer treatment option that can be widely used.

A Promising Future

Belzberg’s research also explores the synergistic potential of combining ivermectin with quercetin to fight prion diseases, including transmissible spongiform encephalopathies (TSEs). Prion diseases encompass a group of fatal neurodegenerative disorders characterized by the misfolding of the prion protein (PrP). The preliminary findings suggest that the anti-prion activities of ivermectin and quercetin, coupled with their modulation of tauopathy, warrant further exploration.

The discovery of ivermectin’s anti-cancer properties opens up new possibilities for cancer treatment. Leveraging the well-known safety and pharmacokinetic profiles of these substances, their development as anticancer agents could be faster and less costly compared to creating entirely new drugs. Moreover, successful repurposing of these compounds may expand anticancer treatments in a cost-effective manner, ultimately improving patient outcomes while reducing healthcare expenses.

In conclusion, ivermectin’s journey from a potential COVID-19 treatment to a breakthrough in cancer therapy represents a significant stride in medical science. By capitalizing on the synergy between ivermectin, fenbendazole, and other complementary substances, we can unlock new avenues in the fight against cancer. It is imperative that further research and exploration are undertaken to fully comprehend the vast potential of these remarkable drugs and their impact on the future of cancer treatment.

Free Speech and Alternative Media are under attack by the Deep State. Real News Cast needs reader support to survive. 

Every dollar helps. Contributions help keep the site active and help support the author (and his medical bills)

Please Contribute via  GoGetFunding